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June Supplement 2011102S Abstractsvisable because of arterial tortuosity, presumed embolic
symptoms and an inadequate proximal ICA neck.
Technical description: After preoperative medical
evaluation, the ICA aneurysm was exposed through an
extended right neck dissection and repaired utilizing a
saphenous vein interposition graft placed over an indwell-
ing shunt. Mobilization of the parotid gland and resection
of the tip of the styloid process facilitated parapharyngeal
space exposure to the base of the skull.
The patient recovered without neurologic deficit and
was discharged on the sixth postoperative day. One-month
follow-up revealed normal neurologic function, normal
carotid duplex examination and a patent reconstruction on
CTA imaging.
Open repair, utilizing a saphenous vein interposition
graft is a feasible option for the management of properly
selected patients presenting with large, symptomatic inter-
nal carotid aneurysms extending to near the base of the
skull.
Author Disclosures: P. J. O’Hara: Nothing to disclose;
B. G. Wood: Nothing to disclose.
SS30.
The Superiority of Carotid Artery Stenting Over End-
arterectomy in Patients with Ongoing Oral Anticoag-
ulant Therapy
Gianluca Faggioli, Rodolfo Pini, Raffaella Mauro, Antonio
Freyrie, Mauro Gargiulo, Sara Gallinucci, Claudio Rapezzi,
Andrea Stella. Vascular Surgery, Unisversity of Bologna,
Bologna, Italy
Objectives: Few studies have addressed the influence
of the management of chronic oral anticoagulant therapy
(OAT) in patients undergoing carotid revascularization.
Aim of our study is to assess the outcome of patients
submitted to endarterectomy (CEA) with OAT converted
to heparin (OAT-CH) and to stenting (CAS) with unmod-
ified OAT, compared with those with no OAT (NOAT).
Methods: Perioperative results of all patients submit-
ted to CEA and CAS in a 5-year period have been analyzed
by Chi-square and Fisher’s tests in term of stroke, death,
myocardial infarction (MI) and hematoma of the access site
requiring surgical evacuation.
Results: In 1006 carotid procedures (512 CEA
[50.8%] and 494 CAS [49.2%]), overall perioperative com-
plications were: 20(1.9%) strokes, 4(0.4%) deaths, 3(0.3%)
MI and 14(1.4%) hematomas. OAT-CH was significantly
associated with higher complication rate in CEA (tab 1). In
CAS results were similar in OAT vs NOAT pts. OAT pts
submitted to CAS had better results compared with
OAT-CH submitted to CEA (tab 2).
Conclusions: OAT management significantly influ-
ences the results of carotid revascularization. Since CAS
under unmodified OAT had a significantly better outcome
compared to CEAwithOAT-CH, carotid revascularization rtrategies should favour CAS rather than CEA in this
etting.
able I. Results in 512 CEA
OAT-CH #22(%) NOAT #490 (%) p
troke 3 (13.6) 5 (1.0) 0.001
eath 1 (4.5) 2 (0.4) 0.01
I 0 (0.0) 3 (0.6) 0.7
ematoma 2 (9.0) 8 (0.9) 0.01
trokeDeath 4 (18.1) 7 (1.4) 0.001
trokedeathMI
hematoma 6 (27.2) 18 (3.6) 0.001
able II.
CEA in OAT-CH
#22(%)
CAS in OAT
#20(%) p
troke 3 (13.6) 0 (0.0) 0.2
eath 1 (4.5) 0 (0.0) 1.0
I 0 (0.0) 0 (0.0) 1.0
ematoma 2 (9.0) 0 (0.0) 0.5
trokedeath 4 (18.1) 0 (0.0) 0.1
trokedeathMI
hematoma 6 (27.2) 0 (0.0) 0.02
uthor Disclosures: G. Faggioli: Nothing to disclose; A.
reyrie: Nothing to disclose; S. Gallinucci: Nothing to
isclose; M. Gargiulo: Nothing to disclose; R. Mauro:
othing to disclose; R. Pini: Nothing to disclose; C.
apezzi: Nothing to disclose; A. Stella: Nothing to dis-
lose.
S31.
iabetes is Not a Predictor of Adverse Outcome after
arotid Revascularization with Carotid Angioplasty
nd Stenting (CAS)
aola De Rango1, Enrico Cieri1, Gianbattista Parlani1,
abio Verzini1, Gioele Simonte1, Giacomo Isernia1, Pier-
iorgio Cao2. 1Vascular and Endovascular Surgery; Uni-
ersity of Perugia, Perugia, Italy; 2Vascular Surgery, Hos-
ital S. Camillo-Forlanini, Rome, Italy
Objectives: Diabetes is prevalent in most patients un-
ergoing carotid revascularization and is suggested as a
arker of poor outcome after carotid endarterectomy
CEA). Data on outcome of diabetic patients undergoing
arotid angioplasty and stenting (CAS) are limited. The aim
f this study was to investigate early and 6-year outcome of
iabetic patients undergoing CAS compared with those of
concurrent CEA series.
Methods: The database of patients undergoing carotid
evascularization for primary carotid revascularization was
ueried from 2001 to 2009. Diabetic patients were defined
s those with established diagnosis and/or receiving oral
ypoglycemic or insulin therapy. Multivariate and Kaplan
eier analyses were performed on perioperative (30 days)
nd late outcomes.
Results: A total of 2,197 procedures, 1,117 by CEA
nd 1,080 by CAS (29% female, mean age71.3 years) were
eviewed. Diabetes was prevalent in 629 (28.6%) and was
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Volume 53, Number 17S Abstracts 103Smost common in CAS than in CEA patients (30.7% vs
26.6%, p0.042). Diabetic patients were younger
(p0.005) and more frequently had hypertension
(p0.015) or coronary disease (p0.019). Perioperative
stroke/death rate was 2.3% (36/1568) in non-diabetic vs
2.7% (17/629) in diabetic patients (p0.54); 3.4% in
diabetic CEA group and 2.1% in diabetic CAS group. At
multivariate analyses diabetes was found predictor of peri-
operative stroke/death only in CEA group (OR 3.04;
95%CI 1.107-8.362; p0.031) but not in CAS group
(p0.45) or in overall patients (p0.38). Six-year survival
was 78.4% in diabetic and 82.5% in non-diabetic (p0.15).
The 6-year risk of late stroke was similar (5.0%) in diabetic
and non diabetic patients. Six-year restenosis estimates
were 5% in diabetic and 8% in non-diabetic patients
(p0.1). Survival, late stroke and restenosis rates between
diabetic and non-diabetic were similar in CAS and CEA
groups.
Conclusions: Diabetic patients are not at greater risk
of perioperative morbidity, mortality and late stroke after
CAS.
Author Disclosures: P. Cao: Nothing to disclose; E.
Cieri: Nothing to disclose; P. De Rango: Nothing to
disclose; G. Isernia: Nothing to disclose; G. Parlani:
Nothing to disclose; G. Simonte: Nothing to disclose; F.
Verzini: Nothing to disclose.
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SS32.
Implementation and Early Results of a Hospital Wide
Program to Reduce the Incidence of Venous Throm-
boembolic Events
Nicholas Morrissey, Benjamin Bradley, Robert Green, Si-
kander Khan, Hope Copperstone, Lisa Mainieri, James
McKinsey. Columbia University College of Physicians and
Surgeons Weill/Medical College of Cornell University,
The New York Presbyterian Hospital, New York, NY
Objectives: Venous thromboembolic disease (VTE) is
a major cause of morbidity and mortality in hospitalized
patients. Despite evidence confirming the benefit of pro-
phylaxis, many patients do not receive prevention and
develop VTE.We implemented and studied a hospital wide
program to assure all patients have VTE risk and prevention
addressed.
Methods: Beginning June 2010, all patients admitted
to a 2,300 bed academic medical center had VTE risk
addressed in their electronic admission orders. Risk assess-
ment and prophylaxis were monitored using Microsoft
AMALGA software and hospital electronic health record
(ECLIPSYS). VTE rates were monitored through chart
review by certified coders. Rates were calculated as VTE per
1000 patient discharges and rates were compared with
chi-square. AMALGA software allowed real-time assess-
ment of all patients risk scores and prophylaxis regimens. Ghe number of discharges from the institution is approxi-
ately 62,000 per year.
Results: Data are shown in table 1. Compared to the
rst half of 2010 VTE decreased significantly after im-
lementation of the program. Compliance with prophy-
axis also doubled after implementation. 32% of patients
eemed low-risk by admitting physician were actually
igh risk. Of these, 65% were already on appropriate
rophylaxis. In the remaining 35%, responsible physi-
ians were contacted and prophylaxis implemented un-
ess contraindicated.
Conclusions: A hospital-wide VTE prevention pro-
ram that evaluates all admitted patients is feasible even in
arge medical centers. Preliminary data suggest that there is
significant decrease in VTE events and significant im-
rovement in prophylaxis rates. The AMALGA software
llows real-time monitoring of risk and prophylaxis result-
ng in the ability to correct errors and provide appropriate
rophylaxis when indicated.
Innappropriate
prophylaxis
Rate of VTE per
1000 discharges
re implementation 46% 5.75
ost implementation 22% 4.22
p.011 p .003
uthor Disclosures: B. Bradley: Nothing to disclose; H.
opperstone: Nothing to disclose; R. Green: Nothing to
isclose; S. Khan: Nothing to disclose; L. Mainieri: Noth-
ng to disclose; J. McKinsey: Nothing to disclose; N.
orrissey: Nothing to disclose.
S33.
mpact of Graduated Compressive Stockings on the
Revention of P-Thrombotic syndrome: Results of a
andomized Trial
rjun Jayaraj, Cynthia Natiello, Stephen Nicholls, Mark
eissner. Vascular Surgery, University of Washington, Se-
ttle, WA
Objectives: Post-thrombotic syndrome (PTS) is a
ommon chronic complication of acute deep venous
hrombosis (DVT) in the lower extremity with as many as
wo-thirds of patients developing symptoms of pain,
dema, hyperpigmentation or ulceration. The role of grad-
ated compressive stockings (30-40mmHg knee length) in
he prevention of PTS has been studied with the opinion
eing divided on the beneficial effects. We aim to answer
his question with a randomized controlled study that used
ultiple scoring instruments to assess post thrombotic
yndrome.
Methods: 69 consecutive patients with an acute
VT diagnosed by duplex ultrasonography were ran-
omized to treatment with graduated compressive
tockings (GCS) or no stockings to assess the impact of
CS on the prevention of PTS. Venous Clinical Severity
